Abstract: Quantum-Enhanced Artificial Intelligence for Affordable Precision Oncology and Early Cancer Detection
Cancer remains one of the most significant global healthcare challenges, with early diagnosis, treatment personalization, and accessibility of advanced medical technologies continuing to be critical priorities. Although Artificial Intelligence (AI) and Machine Learning (ML) have demonstrated remarkable potential in improving cancer detection, medical imaging analysis, biomarker identification, and therapeutic decision-making, the increasing complexity and volume of biomedical data present significant computational challenges. Quantum-Enhanced Artificial Intelligence (QAI), which integrates quantum computing principles with advanced AI methodologies, represents an emerging technological paradigm with the potential to accelerate healthcare innovation and enable more efficient, affordable, and personalized oncology solutions. This presentation explores the transformative potential of Quantum Machine Learning (QML) and quantum-enhanced AI approaches in precision oncology, with a focus on early cancer detection, cost-effective healthcare delivery, and improved clinical decision support. Quantum computing capabilities, including superposition, quantum parallelism, and entanglement, may provide new opportunities to analyze complex biological datasets that exceed the practical limitations of traditional computational approaches. By combining quantum algorithms with deep learning, data analytics, and computational biology, researchers are developing innovative frameworks for identifying hidden patterns within genomic, molecular, imaging, and clinical datasets. One of the most promising applications of quantum-enhanced AI is early cancer detection, where timely diagnosis can significantly improve patient outcomes and survival rates. Modern oncology increasingly relies on high-dimensional data sources, including medical imaging, liquid biopsy results, genomic profiles, and molecular signatures. Quantum-assisted machine learning models have the potential to enhance pattern recognition, improve predictive accuracy, and support the identification of early disease indicators. These advancements may contribute to the development of faster and more reliable diagnostic systems that can support clinicians in detecting cancer at earlier and more treatable stages. Furthermore, quantum-enhanced AI may play a significant role in reducing healthcare costs by enabling more efficient computational processes, optimizing diagnostic workflows, and supporting personalized treatment strategies. Affordable and scalable AI-driven healthcare solutions are particularly important for reducing disparities in access to advanced cancer screening technologies. By improving diagnostic efficiency and enabling targeted therapies, quantum-powered approaches may help minimize unnecessary procedures, optimize resource utilization, and support value-based healthcare models. This presentation also examines the integration of quantum AI with precision medicine and computational oncology. Quantum-enhanced algorithms may improve molecular simulation, accelerate drug discovery, identify potential therapeutic targets, and enable more personalized treatment recommendations based on individual patient characteristics. Such capabilities could transform cancer care from a generalized treatment approach toward a more precise, data-driven, and patient-centered model. Despite its significant promise, quantum-enhanced AI remains an evolving field with challenges related to quantum hardware limitations, algorithm development, data integration, scalability, and real-world clinical implementation. Hybrid quantum-classical approaches are currently being explored as practical pathways for combining existing AI infrastructure with emerging quantum technologies. In conclusion, Quantum-Enhanced Artificial Intelligence represents a promising frontier for advancing affordable precision oncology and early cancer detection. Through the convergence of quantum computing, artificial intelligence, and biomedical innovation, this emerging field has the potential to create more accessible, efficient, and impactful healthcare solutions while addressing some of the most complex challenges in modern cancer research and treatment.